Acute kidney injury: |
● Serum creatinine (at presentation and at baseline), estimated glomerular filtration rate |
● 24-hour urine output (if able to quantify) |
● Urine analysis (especially blood and protein in urine) |
● Urine microscopy |
● Imaging of kidneys (if available) |
● Medication review to evaluate for nephrotoxic medications |
Acute glomerulonephritis/nephrotic syndrome: |
● Hypertension |
● Systemic symptoms/signs (edema, anasarca, arthritis or rash) |
● Urine analysis (especially blood and protein in urine) |
● Urine microscopy (specifically presence or absence of dysmorphic red blood cells or casts) |
● Urine albumin to creatinine ratio (urine protein to creatinine ratio or 24-hour urine protein) |
● Kidney biopsy findings |
Kidney biopsy: |
Light microscopy |
● Number of glomeruli obtained in biopsy sample |
● Proportion of glomeruli affected |
● Description of pathological findings (with hematoxylin and eosin or periodic acid–Schiff staining) and any special staining |
Immunofluorescent microscopy |
● Type of immunoglobulin and complement evaluated |
● Staining pattern (location) and degree (trace to 3+) |
Electron microscopy |
● Significant findings (helpful if images can be included) |
Drug therapies in glomerular disorders: |
● Specify details on immunosuppression regimen for induction and maintenance, mode of administration (oral or intravenous), dose and frequency |
● Include details on evidence of remission or lack of response |
Dialysis therapy: |
● State type of dialysis (intermittent hemodialysis, continuous renal replacement therapy or peritoneal dialysis) |
● Type of dialysis access |
● Dialysis prescription (frequency, duration, composition and volume of dialysate fluid) and any significant machine settings |
Electrolyte and acid–base disorder: |
● Details of electrolyte disorder at baseline and at presentation |
● Appropriate blood and urine tests done to determine cause of electrolyte disorder |
● Treatment offered and if this led to correction of the electrolyte disorder |
Imaging finding: |
● Type of study |
● Specialized imaging (with or without contrast) and images of the radiological studies: ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) |
Kidney transplant recipient: |
● State reason for kidney failure |
● Type of kidney transplant (deceased or living donor) |
● Human leukocyte antigen matching |
● Timing of transplantation |
● Any prior episodes of rejection |
● Prescribed immunosuppressants |
Kidney stone: |
● Presenting symptoms |
● Imaging studies |
● Study of stone composition |
● 24-hour urine studies (if any) |
● Treatment offered (urological intervention or stone prophylaxis) |